logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

TENCENT (00700) spent HK$550 million to repurchase 874,000 shares on September 11th.

date
11/09/2025
avatar
GMT Eight
Tencent Holdings (00700) announced that on September 11, 2025, the company will spend 550 million Hong Kong dollars to repurchase 8...
TENCENT (00700) announced on September 11, 2025 that the company will buy back 874,000 shares at a cost of 550 million Hong Kong dollars, with a buyback price of 624-633 Hong Kong dollars per share.
Related Articles
China Stock
Huanlejia Food Group (300997.SZ): Maoxing Consulting plans to solicit quotations for transferring 1.34% of the company's shares.
HK Stock
GRAND PHARMA (00512) appears at BIOHK2025 Go Global strategy to open up the global innovative drug market.
Strategic execution capability recognized by top institutions, HCW reiterates "buy" rating for Cango Inc Sponsored ADR (CANG.US)
Huanlejia Food Group (300997.SZ): Maoxing Consulting plans to solicit quotations for transferring 1.34% of the company's shares.
China Stock
GRAND PHARMA (00512) appears at BIOHK2025 Go Global strategy to open up the global innovative drug market.
HK Stock
Strategic execution capability recognized by top institutions, HCW reiterates "buy" rating for Cango Inc Sponsored ADR (CANG.US)
RECOMMEND
Hong Kong Stock Concept Tracker|Oracle (ORCL.US) RPO Surge Ignites AI Computing Power Chain—Domestic Opportunities in Focus
Hong Kong Stock Concept Tracker|Oracle (ORCL.US) RPO Surge Ignites AI Computing Power Chain—Domestic Opportunities in Focus
icon
11/09/2025
Southbound Capital Flows Shift: Profit-Taking on High-Flying Stocks and Accumulating Alibaba and Tence
Southbound Capital Flows Shift: Profit-Taking on High-Flying Stocks and Accumulating Alibaba and Tence
icon
11/09/2025
Anti-Involution Policies Deliver Results as August Price Indicators Improve
Anti-Involution Policies Deliver Results as August Price Indicators Improve
icon
11/09/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.